FDA publishes guidance for Inactive Ingredient Database
13 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The FDA has released draft guidance for using the Inactive Ingredients Database to aid drug developers.
List view / Grid view
Formulation
Crystallised drug formulation extends medical device function
4 July 2019 | By Victoria Rees (European Pharmaceutical Review)
A study has shown that crystallising drugs removes localised immune reaction, allowing long-term release of drugs from medical devices.
Global pharmaceutical filler market set to increase 5.7 percent
3 July 2019 | By Victoria Rees (European Pharmaceutical Review)
The filler market is predicted to increase to US$2 billion by 2024, according to a new report.
The impact of counterfeit drugs in south and south-east Asia
3 July 2019 | By Victoria Rees (European Pharmaceutical Review)
Substandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions.
Digital design for pharmaceutical product and process development
1 July 2019 | By Dana Barrasso, Debbie Hooper, Gavin Reynolds, Hervé Barjat, John Henderson, Mike Tobyn
New digital design and manufacturing techniques offer pharmaceutical manufacturers the possibility of a systems-based, digital approach to substantially streamline their design, development and manufacturing processes. The ADDoPT collaborative consortium has been working to explore how emerging process understanding and predictive models can be applied and embedded within industrial workflows to…
Capsosomes: the revolutionary enzyme carriers
1 July 2019 | By Marc Baiget Francesch
Nature can offer inspiration for the synthesis of more effective drug delivery platforms. In this article, Marc Baiget Francesch discusses the potential of capsosomes as a novel, biocompatible, drug delivery system.
Revealed structure of glucagon fibrils could improve drug formulation
27 June 2019 | By European Pharmaceutical Review
Researchers have discovered the formulation of glucagon fibrils, which could inform drug formulation for diabetic patients.
New stable nanoemulsions could change drug delivery
27 June 2019 | By European Pharmaceutical Review
Researchers have developed a method of creating stable nanoemulsions which could be used in new drug delivery processes.
Product hub: Capsugel® ZephyrTM – dry-powder inhalation capsule portfolio
26 June 2019 | By Lonza
Given patient convenience and compatibility with a range of formulations and doses, capsule based dry-powder inhalation (DPI) technology is becoming the preferred DPI drug delivery platform for respiratory and systemic applications.
Scientific poster: The use of EMDEX® in a lactose-free reformulation of cetirizine tablets
24 June 2019 | By JRS Pharma
Spray-dried lactose is widely used as a filler and binder in the pharmaceutical industry, but many adults are not able to digest lactose. Therefore, it is indispensable to provide alternatives to lactose-containing drugs in order to make them suitable for lactose intolerant patients.
Formulation, Development & Delivery In-Depth Focus 2019
20 June 2019 | By European Pharmaceutical Review
This in-depth focus looks into industrial workflow processes and also how nature can provide inspiration for drug delivery.
Expecting the unexpected
20 June 2019 | By James Mellman - Device Manager at Novartis
The increasing complexity of formulations and active biological products raises new challenges for pre-filled syringe development. James Mellman, Device Manager at Novartis, speaks to Nikki Withers about the challenges of selecting the right primary packaging for injectable formulations and how he has learnt to expect the unexpected.
Study reveals the risk inactive ingredients pose
20 June 2019 | By Victoria Rees (European Pharmaceutical Review)
Researchers have found that many pharmaceutical products contain inactive ingredients which can be dangerous to patients.
European Pharmaceutical Review Issue 3 2019
20 June 2019 | By European Pharmaceutical Review
In this issue we explore reasons behind critical key drug shortages in the EU, whether viability methods effectively detect all viable organisms and how companies can future-proof their digital technologies ahead of Brexit. Also included are articles on higher order protein structure, FMD compliance and Raman spectroscopy.
Whitepaper: Good as gold: Capsugel®, Vcaps® Plus capsules
19 June 2019 | By Lonza
Comparative human in-vivo study of an immediate release tablet over-encapsulated by gelatin and hydroxypropyl methyl cellulose capsules –impact of dissolution rate on bioequivalence.
Follow: